Taiwan FDA registration 199029029a379c8939181e214e31d47d
Pukasa Biotechnology in vitro rapid pregnancy test card
TW: 璞笠生技體外快速驗孕卡
Taiwan·Risk Class 2·PULI BIOTECHNOLOGY CO., LTD.·Registered Jul 27, 2022 – Jul 27, 2027ActiveRegistration details
- Analysis ID
- 199029029a379c8939181e214e31d47d
Company information
- Manufacturer
- PULI BIOTECHNOLOGY CO., LTD.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- PULI BIOTECHNOLOGY CO., LTD.
Product details
- Intended Use
- This product is a qualitative in vitro rapid screening reagent that can detect human chorionic gonadotropins in human urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1155 Human chorionic gonadotropin testing system
- Import Information
- QMS/QSD;; 國產
Dates and status
- Registration Date
- Jul 27, 2022
- Expiry Date
- Jul 27, 2027
About this record
Access comprehensive regulatory information for Pukasa Biotechnology in vitro rapid pregnancy test card in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 199029029a379c8939181e214e31d47d and manufactured by PULI BIOTECHNOLOGY CO., LTD.. The authorized representative in Taiwan is PULI BIOTECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices